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Abstract
Phyllanthus emblica Linn. is widely used in Thai traditional medicine for treatment of various diseases. The fruit of
P. emblica is known as a rich source of vitamin C, and also contains a mixture of phenolic compounds. In this study, the
standardized  water  extract  of  P. emblica  fruit  was  prepared  according  to  Thai  Herbal  Pharmacopoeia.  Total  polyphenol
contents of the extract were equivalent to 34.22±1.74 g gallic acid/100g extract. Antioxidant activities of the P. emblica
extract were evaluated by several methods, including DPPH and ABTS
•+ radical scavenging assays and FRAP assays. The
results showed that the extract has an ability of scavenging radicals generated by both DPPH and ABTS
•+. Similar to Trolox,
the water extract of P. emblica fruit also had a ferric reducing property. Additionally, the extract effectively inhibited H2O2-
induced free radical production in human myeloleukemic U937 cells as measured by 2,7-DCF-DA. The results imply that the
fruits of P. emblica are potential sources of natural antioxidants, which have free radical scavenging activity and might be
useful for hepato-, cyto-, and radio- protection, as well as reducing oxidative stress in many pathological conditions.
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1. Introduction
Phyllanthus  emblica  Linn.  (synonym:  Emblica
officinalis  Gaertn.)  is  native  to  the  tropics  of  South  and
Southeast Asia. In Thailand, it is known as Ma-kham-pom.
P. emblica is highly nutritious and is an important dietary
source  of  vitamin  C,  minerals,  and  amino  acids,  such  as
calcium, phosphorus, iron, carotene, thiamine, riboflavin, and
niacin (Department of Medical Sciences, 2000). In P. emblica
fruit, vitamin C is considered to be highly stable due to the
presence of tannin and polyphenols (Morton, 1960). Fruits,
bark,  and  leaves  of  this  plant  are  rich  in  tannin.  Chemical
studies  on  this  plant  reveal  several  norbisabolane  and
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bisabolane derivatives from the root (Zhang et al., 2000;
Zhang et al., 2001b) as well as new galloyl esters of L-malic
acid, mucic acid, and mucic acid 1,4-lactone from the fruit
juice (Zhang et al., 2001c). Later investigation of the fruit
juice  results  in  the  isolation  of  a  new  ellagitannin  and
phyllanemblinin A. In addition, phyllanemblinins B-F have
been found in the leaves and branches (Zhang et al., 2001a).
The ethanol fruit extract shows gastroprotective (Al-
Rehaily et al., 2002), antiproliferative (Khan et al., 2002) and
antioxidant activties (Sai Ram et al., 2002). Furthermore, the
ethyl acetate fruit extract provokes nitric oxide (NO) scaveng-
ing activities (Kumaran and Karunakaran, 2006). The metha-
nol  extract  shows  hepatoprotective  activity  against  CCl4
(Lee et al., 2006), and chemopreventive potential for hepato-
carcinogenesis (Sultana et al., 2008). In addition, the water
fruit extract shows anti-carcinogenesis (Jeena et al., 1999),
hepatoprotective  activity  against  CCl4  (Jose  and  Kuttan,
2000), anti-tumor (Jose et al., 2001), and radioprotective effect
against gamma irradiation (Singh et al., 2005, 2006).
In the present study, the water extract from fruit of P.
emblica was prepared according to Thai Herbal Pharmaco-
poeia (THP). Antioxidant activity of the extract was investi-
gated by several different methods, including DPPH and
ABTS
•+ radical scavenging assays as well as ferric reducing
antioxidant power (FRAP) assay. Furthermore, the antioxi-
dant effect of the extract was confirmed by measuring the
levels  of  intracellular  peroxides  in  human  myeloleukemic
U937 cells.
2. Materials and Methods
2.1 Plant material
The fruits of P. emblica were collected from the forest
of Nan Province, Thailand. The voucher specimen (PBM
01402) is kept at the Faculty of Pharmacy, Mahidol University,
Bangkok, Thailand.
2.2 Preparation of plant extract
The water extract of P. emblica fruits was prepared as
briefly described as follows: 194 kilograms of P. emblica dried
fruit were boiled with water for 1 h and filtered; the procedure
was repeated three times. The extract was spray dried and
standardized by high performance liquid chromatography
(HPLC)  using  gallic  acid  as  a  reference  standard.  The
percentage yield was 8.76 of raw materials in which a content
of  gallic  acid  is  20.5  % w/w  of  dried  extract.  The  quality
control of raw materials and the extract was followed by Thai
Herbal  Pharmacopoeia  (Department  of  Medical  Sciences,
2000).
2.3 Determination of total polyphenols
Total phenolic content of the P. emblica extracts was
determined by Folin-Ciocalteu reagent (Kumazawa et al.,
2002). The assay reaction contained the mixture of 10 mg/ml
extract  and  the  Folin-Ciocalteu  reagent  (Merck  Chemical
Supplies, Darmstadt, Germany) and 10% Na2CO3 in each 0.5
ml, which were incubated at room temperature for 1 h. The
absorbance was measured by spectrophotometer at 760 nm.
The calibration curve of polyphenols was prepared using
gallic acid as standard in concentration range 2-8 mg/L. The
phenolic content was expressed as grams of gallic acid in
100g of crude extract.
2.4 DPPH radical scavenging assay
The free radical scavenging of the extract was deter-
mined using 1, 1-diphenyl-2-picrylhydrazyl (DPPH) assay
(Brand–Williams et al., 1995). All extracts were prepared in
various concentrations from 10-200 µg/mL in 50% methanol
solution.  The  reaction  assay  contained  3  ml  of  0.060  mM
DPPH (Sigma Chemical Co. St. Louis, MO, USA) in methanol
and  200  µL  of  extract  solution.  The  reaction  mixture  was
incubated in the dark at room temperature for 30 min. The
absorbance of the mixture was measured by spectrophoto-
meter at wavelength 517 nm. Gallic acid was used as refer-
ences  and  50%  methanol  solution  was  used  as  vehicle
control. The ability to scavenge DPPH radical was calculated
by the following equation:
DPPH radical scavenging activity (%)
=  [(Abscontrol - Abssample) / (Abscontrol)] x 100.
2.5 ABTS•+ radical scavenging assay (Re et al., 1999)
The  ABTS
+  radical  was  generated  by  a  reaction
between 7 mM ABTS (2,2'-azinobis-3-ethylbenzothiazoline-6-
sulfonic acid) (Sigma Chemical Co. St. Louis, MO, USA) and
4.9 mM potassium persulfate in water. Sample solution 50 mL
with  various  concentrations  was  mixed  with  3  ml  ABTS
•+
solution and the absorbance was measured at 734 nm at 6
min. The % reduction of ABTS
•+ content represented as the
inhibitory effect of sample. Trolox was used as standard and
50%  methanol  solution  was  used  as  vehicle  control.  The
ability  to  scavenge  ABTS
•+  radical  was  calculated  by  the
following equation:
ABTS
•+ radical scavenging activity (%)
=  [(Abscontrol - Abssample) / (Abscontrol)] x 100.
The antioxidant activity of extract was also expressed
as trolox equivalent antioxidant capacity (TEAC), which was
the ratio of % inhibition of sample to that of Trolox at the
same concentration. All experiments were done in triplicate
for each concentration.
2.6 Ferric reducing antioxidant power (FRAP) assay
The reducing ability of the plant extract using ferric
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was preformed by the mixture of 4.5 mL FRAP reagent (Sigma
Chemical Co. St. Louis, MO, USA), 450 mL double distilled
water and 150 mL sample or Trolox as standard positive
control.  Then,  the  reaction  assay  was  incubated  at  room
temperature in the dark for 30 min. Absorbance was moni-
tored at 595 nm. All experiments were done in triplicate for
each concentration. The production of ferrous sulfate by the
extract  was  calculated  using  a  standard  curve  of  ferrous
sulfate. The antioxidant activity of extract was expressed as
µmole of FeSO4 per mg of the extract and compared with that
of Trolox.
2.7 Determination of cellular antioxidant status
Human myeloleukemic U937 cells were maintained in
RPMI (Gibco, Invitrogen, USA) containing 10% fetal bovine
serum, penicillin G (100 IU/mL), streptomycin (100 g/mL),
and L-glutamine (2 mM) and incubated at 37°C in a 5% CO2
atmosphere. Various concentrations of the extract were added
to 5x10
5 cells/plate in a serum-free RPMI medium and incu-
bated for 24 hrs. The cells were washed twice with phenol
red-free HBSS.
The production of intracellular peroxides was deter-
mined by 2,7-DCF-DA (Molecular Probe, Invitrogen, USA)
which indicates the antioxidant activity of the extract. Cells
were loaded with 10 µM H2DCF-DA in phenol red-free HBSS
and incubated for 45 min. After cells were washed once by
phenol red-free HBSS and only 4x10
4 cells in 100 mL HBSS
were added into 96-well plate. Hydrogen peroxide (2mM) was
used to induce oxidative stress for 30 min. The fluorescence
values before and after addition of hydrogen peroxide were
measured using a fluorescence plate reader (485-nm excita-
tion and 530-nm emission, Packard Fusion
TM) and referred as
the stress and background fluorescence level. Phenol red-
free HBSS was used as control. The antioxidant activity was
calculated by the following equation:
Antioxidative capacity (%)
= [(FLstress - FLbackground) control] / [(FLstress - FLbackground) test]
3. Result and Discussion
Previous studies have reported the fruits of P. emblica
contain phenolic compounds and hydrolysable tannins. In
our study, total polyphenol contents of the water extract of
P. emblica were equivalent to 34.22±1.74 g gallic acid/100g
extract. Similarly, Naik et al. (2005) reported 33% gallic acid
equivalents  of  the  total  phenolic  content  present  in  the
aqueous extract of this fruit. A variety of phytochemicals in
P. emblica fruit has been identified including hydrolysable
tannins (such as emblicanin-A, emblicanin-B, punigluconin,
and pedunculagin), gallo-ellagitannoids, flavonoid (rutin),
trigalloyl glucose, and phyllemblic acid (Ghosal et al., 1996,
Pillay  et  al.,  1988).  In  addition,  this  fruit  has  been  long
claimed to be a rich source of ascorbic acid. However, it is
still inconclusive whether the fruit of P. emblica does contain
ascorbic acid since various methods of estimation were used
in each study. Ghosal et al. (1996) reported that the strong
antioxidant action of P. emblica does not result from either
the free or the conjugated form of ascorbic acid, but rather
the presence of the hydrolysable tannins. In contrast, the
earlier reported antioxidant hydrolysable tannins, emblica-
nins  A  and  B  were  validated  in  fact  corresponding  to  -
glucogallin and  mucic  acid  1,4-lactone  5-O-gallate,  respec-
tively (Pozharitskava et al. 2007). Moreover, several studies
asserted that P. emblica in deed contains a high content of
ascorbic acid; 0.34-0.38% (Raghu et al., 2007) and 0.40%
(Scartezzini et al., 2006) w/w of the fruit which accounts for
45-70%  of  the  antioxidant  activity.  Recently,  a  study  using
multiple HPLC methods found small amounts of free ascorbic
acid in P. emblica fruit (Majeed et al. 2009). Nonetheless, the
fruit  of  P. emblica  has  been  proved  as  a  good  source  of
natural antioxidants used for scavenging free radicals and
reducing oxidative stress.
Antioxidant activities of the water extract of P. emblica
fruit  were  evaluated  herein  by  measuring  its  ability  of
scavenging free radical generated by DPPH and ABTS
•+ and
reducing ferric to ferrous (FRAP assay). As shown in Figure
1, 2 and Table 1, the inhibition of DPPH and ABTS
•+ as well as
the reduction of ferric ions to ferrous sulfate by the extract
were dose-dependent. Fifty percent inhibition of DPPH and
Figure 1. Antioxidant activity measured by DPPH assay of water
extract of P. emblica.
Figure 2. Antioxidant activity measured by ABTS
•+ assay of water
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ABTS
•+ were achieved at approximately 50 and 300 µg/mL of
the extract, respectively. Noticeably, as the gallic acid content
in our extract was 20% w/w, the 50% DPPH inhibitory dose
(IC50) of the extract should be equivalent to approximately
10 µg/mL of gallic acid. This is similar to IC50 of the standard
gallic acid (8.5 µg/mL) for DPPH activity as shown in Table 1.
Therefore, it is possible that gallic acid in the extract plays a
major role in DPPH radical scavenging activity. In addition,
the extract of P. emblica was able to reduce ferric ion to
FeSO4 (7.46±0.56 µmole of FeSO4/mg) which is about 0.89
fold compared to Trolox (8.35±0.16 µmole of FeSO4/mg) in
Figure 3 and Table 2.
Cellular antioxidant effect of the water extract of P.
emblica fruit was further evaluated in human myeloleukemic
U937 cells by DCF assay measuring the levels of intracellular
reactive oxygen species (ROS) induced by H2O2. The result
showed that the fruit extract can inhibit the production of
intracellular ROS in a dose dependent manner (Figure 4). The
concentration of the extract for 50% ROS inhibition was 0.62
µg/mL, which is higher than that of gallic acid (IC50 = 4.28
µg/mL).  The  results  thus  indicated  that  P. emblica  fruit
extract  not  only  has  radical  scavenging  activity,  but  also
shows efficacy as a strong inhibitor against H2O2-induced
cellular oxidative stress.
The results of these assays suggested that the anti-
oxidant activity of extract does not depend upon only one
particular compound. An earlier study by Scartezzini et al.
(2006) showed that the antioxidant activity of aqueous extract
of processed fruit is due to ascorbic acid for only 60% or less.
Furthermore,  hydrolysable  tannins  can  also  exhibit  a  very
strong  antioxidant activity in vitro and in vivo (Ghosal et al.,
1996, Bhattacharya et al., 2000). The fruit extract of P. emblica
also significantly inhibited chromium-induced free radical
production and restored the antioxidant status in lympho-
cytes back to normal level (Sai Ram et al., 2002). Thus, the
antioxidant activity of P. emblica is likely attributed to its
cytoprotective property.
In conclusion, the water extract of P. emblica fruit
prepared  according  to  Thai  Herbal  Pharmacopoeia  has  a
strong potential for free radical scavenging, ferric reducing
as well as inhibiting ROS production. The results imply that
the fruits of P. emblica are potential sources of natural anti-
oxidants useful for hepato-, cyto- and radio- protection as
well as reducing oxidative stress in many pathological con-
ditions.
Table 1. Effect of in vitro antioxidant activity of P. emblica.
                              IC50 (ug/mL)
Assay Relative to standard
P. emblica Standard(*gallic acid, **Trolox)
DPPH   51.3±16.5 8.5±0.7* 0.182±0.070*
ABTS
•+ 295±5.4     177±3.22**    0.600±0.011**
DCF   0.65±0.04 4.48 ±1.32* 6.90±1.15*
(n=3; values are mean ± S.D.)
Table 2. Effect of ferric reducing activity of P. emblica.
Treatment FeSO4 (umole/mg) Relative to Trolox
P. emblica 7.46±0.56 0.893 ± 0.067
Trolox 8.35 ±0.16 1.000 ± 0.019
(n=3; values are mean ± S.D.)
Figure 3. Antioxidant activity measured by FRAP assay (expressed
as µmole of FeSO4) of water extract of P. emblica.
Figure 4. Antioxidant activity measured by DCF assay (expressed
as % ROS inhibition) of water extract of P. emblica.603 J. Charoenteeraboon et al. / Songklanakarin J. Sci. Technol. 32 (6), 599-604, 2010
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